Document de presse | 2021.01.25
Since early 2020, the Institut Pasteur has been engaged in research in several of its areas of scientific expertise, including virology, diagnostics, pathophysiology, epidemiology, modeling, therapeutic research and vaccine research. A number of research programs to find a vaccine for SARS-CoV-2, the virus responsible for the COVID-19 epidemic, are under way. In light of the intermediate results...
Document de presse | 2021.06.22
Over the past 16 months and against the backdrop of the COVID-19 health crisis, thousands of drugs have been tested with a view to repurpose them to tackle SARS-CoV-2. Many of these drugs have demonstrated potential antiviral activity (23 compounds including hydroxychloroquine, azithromycin, amiodarone and 4 others tested in clinical trials). Given this high number of potential treatments, the...
News | 2023.07.10
Developing effective therapeutic vaccines requires knowing how to chemically recognize microbes, as well as exposing them to treatment. Able to mutate very quickly and to camouflage itself inside the cells it infects, the AIDS virus (or HIV) constitutes a challenge for researchers.
Article | 2025.02.20
The Institut Pasteur MD-PhD program is designed to bridge the gap between fundamental, applied research and clinical practice, equipping physicians with the skills needed to tackle the increasingly complex healthcare challenges of today. This program offers opportunities for medical students and doctors to improve patient care and in parallel foster innovation in medical sciences.
Document de presse | 2014.06.01
Neisseria meningitidis, also called meningococcus, is a bacterium responsible for meningitis and septicemia[1]. Its most serious form, purpura fulminans, is often fatal. This bacterium, which is naturally present in humans in the nasopharynx, is pathogenic if it reaches the blood stream. Teams led by Dr. Sandrine Bourdoulous, CNRS senior researcher at the Institut Cochin (CNRS/INSERM/Université...
Document de presse | 2014.10.13
Erosive oral lichen planus (OLP) is an auto-immune disease affecting skin and mucous membranes which results in an abnormal immune response against mucocutaneous cells. Today, scientists at the Institut Pasteur, Inserm, Paul Sabatier University (Toulouse) and the CNRS have proven that the immune cells involved in OLP are the same as those activated during an immune response to human...
Document de presse | 2008.10.07
How research into hereditary deafness has revealed the way in which the inner ear distorts sounds A study carried out by researchers from the Institut Pasteur and Inserm, published in the journal Nature, has revealed how the inner ear distorts sounds. This distortion is one of the essential stages in the processing of sound by the ear, before this sound is encoded so that it can be transmitted to...
Document de presse | 2005.06.14
Researchers from the CNRS and the Institut Pasteur, members of the European Network of Excellence MYORES report on the embryonic origins of muscle stem cells. These results, published in two Nature papers on June 16th, 2005, lead to a better understanding of the muscle development. Press release Paris, june 15, 2005 Muscle stem cells exist in the embryo and in the...
Fiche maladie | 2015.10.06
Sepsis is the term used internationally to describe a widespread inflammatory response that occurs as a result of severe infection. Septicemia, the term coined in 1837 by French doctor Pierre Piorry from the Greek words "σήψις" (sêptikós), putrefaction, and "αίμα" (haîma), blood, refers to the presence of bacteria (or fungi or viruses) in the blood. Sepsis primarily affects people with weak...
Fiche maladie | 2015.10.06
Malaria is a disease transmitted by parasites of the genus Plasmodium. According to WHO figures, the disease caused 608,000 deaths worldwide in 2022. For several years now, parasites have been developing resistance to antimalarial drugs and mosquitoes are increasingly less susceptible to insecticides.